一例猫乳头状肾癌的诊治报告
摘要
笔者通过对一例猫乳头状肾癌病例进行治疗和持续性跟踪,探究该类型疾病的治疗方法以及可能有效的化疗方案。
出处
《当代畜牧》
2018年第12期33-35,共3页
Contemporary Animal Husbandry
二级参考文献44
-
1MOTZER RJ, BUKOWSKI RM. Targeted therapy for metastatic renal cell carcinoma [ J ]. J Clin Oncol, 2006,24 ( 35 ) : 5601 - 5608.
-
2FACCHINI G, PERRI F, CARAGLIA M, et al. New treatment approaches in renal cell carcinoma [J]. Anti Cancer Drugs, 2009, 20(10) :893 -900.
-
3KAELIN WG JR. The von Hippel-Lindau tumor suppressor gene and kidney cancer[J]. Clin Cancer Res,2004, 10(18 Pt2) : 6290S - 6295S.
-
4MULDERS P. Vascular endothelial growth factor and roTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms[ J]. BJU Int, 2009, 104( 11 ) : 1585 - 1589.
-
5HOFMOCKEL G, RIESS S, BASSUKAS ID, et al. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact[J]. Eur Urol, 1997, 31 (4) :478-484.
-
6SCHMIDT L, DUH FM, CHEN F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas [J]. Nat Genet, 1997, 16 (1): 68 -73.
-
7ESCUDIER B, EISEN T, STADLER WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma [ J ]. N Engl J Med, 2007, 356(2) :125 - 134.
-
8ESCUDIER B, EISEN T, STADLER WM, et al. Sorafenib for treatment of renal cell carcinoma : Final efficacy and safety results of the phase Ⅲ treatment approaches in renal cancer global evaluation trial[J]. J Clin Oncol, 2009, 27(20): 3312 -3318.
-
9KNOX J, FIGLIN R, STADLER W, et al. The advanced renal cell carcinoma sorafenib(ARCCS) expanded access trial in North America: Safety and efficacy [J]. J Clin Oncol, 2007, 25: 5011.
-
10ESCUDIER B, SZCZYLIK C, HUTSON TE, et al. Randomized phase Ⅱ trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma[J]. J Clin Oncol, 2009, 27(20): 1280- 1289.
共引文献21
-
1刘亚贤,赵宏然,孙丹凤,赵海.甲苯磺酸索拉非尼及其联用维生素C对原发肝癌的疗效分析[J].黑龙江医学,2013,37(2):101-103. 被引量：2
-
2苑宝山.索拉非尼治疗转移性肾癌的临床疗效研究[J].现代预防医学,2012,39(12):3138-3139. 被引量：4
-
3杨雅雯,董莹,任既晨.索拉非尼与白介素联合治疗晚期肾癌的效果分析[J].中国卫生标准管理,2015,6(22):104-105.
-
4陈旭,张洪秀,聂明秀,李伟.肾细胞癌精准靶向治疗的研究进展[J].中国当代医药,2016,23(21):14-18. 被引量：2
-
5任雨,石炳毅.转移性肾癌的循环肿瘤分子标志物在靶向治疗中的研究进展[J].中国现代医生,2016,54(33):160-164. 被引量：1
-
6彭庆.三氧化二砷联合西罗莫司体外抑制人肾癌细胞786-O增殖及对PI3K/Akt/mTOR通路的影响[J].解剖学研究,2017,39(2):106-109. 被引量：3
-
7薛林雁,杨昆,曹彪,闫惟娜,刘雨航,刘爽.飞秒脉冲激光产生及捕获微气泡的实验研究[J].河北大学学报（自然科学版）,2019,39(4):359-365. 被引量：3
-
8王贤淼.VEGFR肿瘤靶向药物研究进展分析[J].生物化工,2019,5(3):121-124. 被引量：4
-
9张娜,佟旭,王大鹏,李义强,周煜.盐酸安罗替尼在常见恶性肿瘤中的研究进展[J].齐齐哈尔医学院学报,2019,40(23):2992-2995. 被引量：3
-
10黄云美,梁菊华,许桂丹.分子病理技术在临床诊疗中的应用进展[J].右江医学,2020,48(2):137-140. 被引量：2
